VCEL
Biotechnology · Healthcare
CEO, Board Member
2025-04-30–present
Board Member
Vericel Corp (VCEL)Equibles does not estimate personal net worth.
Get an email with a short summary when Vericel Corp publishes a filing, an earnings call transcript or a press release.
Get VCEL alertsDominick Colangelo is recorded as Board Member at Vericel Corp (VCEL) since April 30, 2025 and CEO at Vericel Corp (VCEL). Vericel Corp reported in an 8-K filed May 2, 2025 that Dominick Colangelo was appointed director, effective April 30, 2025. Vericel Corp reported in an 8-K filed May 5, 2023 that Dominick Colangelo was appointed director, effective May 3, 2023. The proxy statement of Vericel Corp reports total compensation of $11,156,368 for Dominick Colangelo in fiscal 2025, including a base salary of $860,000. Disclosed compensation is on record for 7 fiscal years. Dominick Colangelo has spoken on 1 earnings call across 1 company, most recently for Vericel Corp on November 6, 2025. Vericel Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vericel Corp includes Joseph A. Mara (CFO), Michael Halpin (COO), Sean C. Flynn (General Counsel) and 7 others.
“the election of each of Robert Zerbe, Alan Rubino, Heidi Hagen, Kevin McLaughlin, Paul Wotton, Lisa Wright and Dominick Colangelo as a director of the Company to serve for a one-year term expiring at the Company's 2026 annual meeting of shareholders and until his or her successor has been elected and qualified”
“the election of each of Robert Zerbe, Alan Rubino, Heidi Hagen, Steven Gilman, Kevin McLaughlin, Paul Wotton, Lisa Wright and Dominick Colangelo as a director of the Company to serve for a one-year term expiring at the Company’s 2024 annual meeting of shareholders and until his or her successor has been elected and qualified”
“The company delivered outstanding financial and business results in the third quarter with strong top-line revenue growth and even higher profit growth, a significant inflection in operating cash flow, and continued progress across a number of key business initiatives.”
2025-04-30–present
VCEL
Biotechnology · Healthcare
CEO, Board Member
2025-04-30–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vericel Corp (VCEL) | President and CEO | $860,000 | $11,156,368 |
| 2024 | Vericel Corp (VCEL) | President and CEO | $830,000 | $10,237,525 |
| 2023 | Vericel Corp (VCEL) | President and CEO | $790,000 | $7,056,422 |
| 2022 | Vericel Corp (VCEL) | President and CEO | $760,000 | $8,708,367 |
| 2021 | Vericel Corp (VCEL) | President and CEO | $730,000 | $13,183,295 |
| 2020 | Vericel Corp (VCEL) | President and CEO | $675,000 | $4,412,718 |
| 2019 | Vericel Corp (VCEL) | President and CEO | $634,000 | $5,385,527 |